From Variability to Value: Measuring Heterogeneity in Bioprocesses


Abstract

Bioprocesses harness nature’s ingenuity but, in doing so, introduce significant heterogeneity with often unforeseen consequences for process performance and product quality. While this variability is frequently viewed as a challenge, it also presents an opportunity—provided it can be effectively measured and understood. In this talk, we explore how analytical approaches can reveal heterogeneity across key stages of bioprocessing, from variability within affinity chromatography eluates and its implications for product variants, to the unexpected co-purification mechanisms of host cell proteins.
We further examine heterogeneity in separation materials, including ligand density variations and their impact on process robustness. Finally, we consider increasingly complex products such as viral vectors, where both structural diversity and time-dependent behaviour during sorption introduce new measurement dimensions. Together, these examples illustrate how robust measurement strategies enable deeper process insight, supporting Quality by Design approaches and ultimately transforming variability into a source of value in modern biomanufacturing.

About the Speaker(s)

Daniel G. Bracewell is Professor of Bioprocess Analysis at the UCL Department of Biochemical Engineering. His notable contributions have significantly advanced our understanding of biological product purification, often through collaborations with industry leaders. He has authored over 100 peer-reviewed journal articles, many of which involve fruitful partnerships with esteemed institutions in Thailand, India, and the USA. Currently, he oversees 12 doctoral and postdoctoral projects. 

One particularly impactful project led to the creation of Puridify, a nanofiber adsorption technology company now owned by Cytiva. As the academic lead for the UCL-Cytiva Centre of Excellence, Daniel is at the forefront of pioneering efforts in bioprocessing. His current focus involves the development of cell-free /enzymatic manufacturing technologies and separations for gene delivery vectors, aimed at facilitating targeted healthcare.

Under the Spotlight
Latest news